Evidence map›Paper›PMID 41454148›Full record

ArticlePediatric research2026

Association of DLK1-MEG3 methylation levels in cord blood with small for gestational age.

Yuyuan Bu, Yuye Jiang, Dan Long, Zhenghong Zhu, Jie Ni, Wei Wu, Jingjin Gong, Miaochan Zhu, Cunrui Huang, Qing Wang and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yuyuan BuSchool of Public Health, Sun Yat-sen University, Guangzhou, China.
Yuye JiangSchool of Public Health, Sun Yat-sen University, Guangzhou, China.
Dan LongSchool of Public Health, Sun Yat-sen University, Guangzhou, China.
Zhenghong ZhuSchool of Public Health, Sun Yat-sen University, Guangzhou, China.
Jie NiSchool of Public Health, Sun Yat-sen University, Guangzhou, China.
Wei WuSchool of Public Health, Sun Yat-sen University, Guangzhou, China.
Jingjin GongGuangzhou Panyu Maternal Child Health Hospital, Guangzhou Panyu District He Xian Memorial Hospital, Guangzhou, China.
Miaochan ZhuGuangzhou Panyu Maternal Child Health Hospital, Guangzhou Panyu District He Xian Memorial Hospital, Guangzhou, China.
Cunrui HuangVanke School of Public Health, Tsinghua University, Beijing, China.
Qing WangSchool of Public Health, Sun Yat-sen University, Guangzhou, China.
Qiong WangSchool of Public Health, Sun Yat-sen University, Guangzhou, China. wangqiong@mail.sysu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe DLK1-MEG3 gene locus on human chromosome 14q32.2 contributes significantly to glucose metabolism and is linked to SGA development, but the role of its methylation in glucose regulation and SGA remains unclear.

methodsA nested case-control study of 330 participants (165 SGA, 165 AGA) measured methylation levels of IG-DMR (5 CpGs) and MEG3-DMR (7 CpGs) in umbilical cord blood using bisulfite pyrosequencing. Blood glucose and insulin levels were assessed. Logistic regression and mediation analysis were used.

resultsHigher IG-DMR (Pos. 3) methylation level was associated with elevated SGA risk (OR = 1.068, 95% CI [1.002-1.142]) and lower blood glucose (Percentage change = -2.69%, 95% CI [-4.75% to -0.58%]). The average methylation level of MEG3-DMR was negatively correlated with SGA risk (OR = 0.931, 95% CI [0.876 to 0.987]) and positively with insulin (Percentage change = 3.38%, 95% CI [0.23% to 0.63%]). Mediation analysis suggested insulin mediated the effect between the average methylation level of MEG3-DMR and SGA (explaining 11.7%). After excluding preterm infants, the association between the average methylation level of MEG3-DMR and insulin was not significant, while other results remained similar.

conclusionThese results offer new insights into how DNA methylation influences pregnancy outcomes and provide a foundation for SGA management and prevention research. IMPACT: Epigenetic changes, such as DNA methylation, are believed to play a significant role in regulating intrauterine growth. The DLK1-MEG3 locus, which includes two differentially methylated regions (IG-DMR and MEG3-DMR) is involved in glucose metabolism regulation, a key factor in fetal growth. We identified a marked association of the mean methylation levels of MEG3-DMR and SGA, and insulin may mediate this association. The findings offer novel insights into the epigenetic mechanisms linking DNA methylation patterns with adverse gestational consequences. This research has potential implications for improving the management of SGA risk.

Indexed as

Calcium-Binding ProteinsDNA MethylationFetal BloodInfant, Small for Gestational AgeIntercellular Signaling Peptides and ProteinsMembrane ProteinsRNA, Long NoncodingAdultBlood GlucoseCase-Control StudiesCpG IslandsDevelopmental Origins of Health and DiseaseEpigenesis, GeneticFemaleHumansInfant, NewbornBlood GlucoseCalcium-Binding ProteinsDLK1 protein, humanInsulinIntercellular Signaling Peptides and ProteinsMEG3 non-coding RNA, humanMembrane ProteinsRNA, Long Noncoding

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.